Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HTI), sold 25,000 shares at $10.21 ($258K) on 2007-04-30, disclosed to the SEC on 2007-05-01.
Scheduled sale ($258k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.20 | 500 | $5K | 2.0% |
| 2 | $10.21 | 300 | $3K | 1.2% |
| 3 | $10.22 | 200 | $2K | 0.8% |
| 4 | $10.23 | 300 | $3K | 1.2% |
| 5 | $10.24 | 800 | $8K | 3.2% |
| 6 | $10.25 | 2,100 |
| $22K |
| 8.3% |
| 7 | $10.26 | 200 | $2K | 0.8% |
| 8 | $10.27 | 100 | $1K | 0.4% |
| 9 | $10.28 | 800 | $8K | 3.2% |
| 10 | $10.29 | 400 | $4K | 1.6% |
| 11 | $10.30 | 4,800 | $49K | 19.2% |
| 12 | $10.31 | 2,100 | $22K | 8.4% |
| 13 | $10.32 | 1,000 | $10K | 4.0% |
| 14 | $10.33 | 1,800 | $19K | 7.2% |
| 15 | $10.34 | 800 | $8K | 3.2% |
| 16 | $10.35 | 3,000 | $31K | 12.0% |
| 17 | $10.36 | 800 | $8K | 3.2% |
| 18 | $10.37 | 500 | $5K | 2.0% |
| 19 | $10.38 | 3,850 | $40K | 15.5% |
| 20 | $10.39 | 200 | $2K | 0.8% |
| 21 | $10.40 | 200 | $2K | 0.8% |
| 22 | $10.48 | 100 | $1K | 0.4% |
| 23 | $10.49 | 100 | $1K | 0.4% |
| 24 | $10.50 | 50 | $525 | 0.2% |
| Total | $10.32 avg | 25,000 | $258K | 100% |
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |